Annals Internal Medicine, Author Interviews, CDC, Infections / 29.03.2023 Interview with: Dr. Meghan Lyman MD Medical Officer in the Mycotic Diseases Branch CDC What is the background for this study? Response: Candida auris (C. auris) is a fungus considered an urgent public health threat because it is often multi-drug resistant and spreads easily in healthcare settings.  CDC has been conducting tracking cases and is concerned about increasing numbers and geographic spread of C. auris cases in recent years, suggesting increased transmission.  Because C. auris cases and resistance are rising in the U.S., immediate public health actions to stop this threat are critical. (more…)
Addiction, Author Interviews, CDC, PLoS, Race/Ethnic Diversity, UCLA / 23.03.2023 Interview with: Maria-Rita D'Orsogna Ph.D. Professor, Mathematics California State University, Northridge Adjunct Associate Professor Department of Computational Medicine at UCLA What is the background for this study? Response: Drug overdose deaths have been increasing in the USA for the past two decades. A ‘third wave’ of overdose fatalities started in 2013, with a shift from prescription opioids towards synthetic ones, in particular illicit fentanyl. To examine trends in drug overdose deaths by gender, race and geography in the United States during the period 2013-2020, we used an epidemiological database provided by the Centers for Disease Control and Prevention, extracting rates by race and gender in all 50 states plus the District of Columbia. We considered the impact of four main drug categories psychostimulants with addiction potential such as methamphetamines; heroin; prescription opioids and synthetic opioids such as fentanyl and its derivatives. (more…)
Accidents & Violence, Author Interviews, JAMA, Pediatrics / 20.12.2022 Interview with: Rebecca F. Wilson, PhD Division of Violence Prevention National Center for Injury Prevention and Control US Centers for Disease Control and Prevention, Atlanta, Georgia What is the background for this study? What are the main findings? Response: Our report shows the homicide rate among children aged 0 to 17 years has been increasing annually on average 4.3% since 2013, and rose sharply from 2019 to 2020. The largest 2019 to 2020 rate increases were among children 11-17 years old, boys, and Black children. Overall increases varied by geography and demographics, with some racial and ethnic disparities persisting for more than 20 years. Firearms were the most common weapon used in child homicides. Homicides of younger children (infants to 10 years) were mostly perpetrated by parents and caregivers and precipitated by abuse and/or neglect. Homicides of older children (11-17 years) were mostly perpetrated by someone known to them, like a friend or acquaintance, and precipitated by crime, arguments, and community violence. (more…)
Author Interviews, CDC, Cost of Health Care, Hepatitis - Liver Disease / 05.10.2022 Interview with: William W. Thompson, Ph.D. Epidemiologist Division of Viral Hepatitis CDC What is the background for this study? Response: Prior to this analysis, we knew only an estimated 1.2 million persons initiated hepatitis C treatment with DAA agents in the United States during 2014–2020, far below the number needed to achieve national hepatitis C elimination goals. Further, the number of persons treated was highest in 2015 and declined to its lowest level in 2020. This analysis used a large national health care claims database to assess the level and timing of hepatitis C treatment among persons with diagnosed HCV infection with breakdowns by sex, age, race, insurance type (i.e., private, Medicaid, and Medicare), and by state. (more…)
Author Interviews, CDC, COVID -19 Coronavirus, Emory, Heart Disease, JAMA / 25.01.2022 Interview with: Matthew Oster, MD, MPH CDC COVID-19 Response CDC Center on Birth Defects and Developmental Disabilities Pediatric Cardiologist, Sibley Heart Center, Children’s Healthcare of Atlanta Emory University School of Medicine Emory University Rollins School of Public Health  What is the background for this study?  What are the main findings? Response: More than 192 million people ages 12 years and older in the U.S. received at least one dose of mRNA COVID-19 vaccines from December 2020 through August 2021. From this population, VAERS (the Vaccine Adverse Event Reporting System) received 1,991 reports of myocarditis,  1,626 of which met the case definition of myocarditis. Rates of myocarditis were highest following the second dose of an mRNA vaccine among males aged 12–15 years (70.7 per million doses of Pfizer), 16-17 years (105.9 per million doses of Pfizer), and 18–47 years (52.4 and 56.3 per million doses of Pfizer and Moderna, respectively). Of those with myocarditis, the median age was 21 years and the median time from vaccination to symptom onset was two days. Males accounted for 82% of patients for whom sex was known. Approximately 96% were hospitalized, 87% of whose symptoms had gone away by the time they were discharged from the hospital. Non-steroidal anti-inflammatory drugs (589/676, 87%) were the most common treatment. (more…)
Author Interviews, CDC, COVID -19 Coronavirus / 06.04.2021 Interview with: Michael S. Pollard Ph.D Senior Sociologist; Professor Pardee RAND Graduate School What is the background for this study? Response: The Centers for Disease Control and Prevention (CDC) has traditionally been a highly trusted source of public health information, and conveying information to the public about the vaccine and broader pandemic response is critical.  This study examines changes in levels of public trust in the CDC between May and October, 2020, in light of the numerous challenges the CDC initially faced during the COVID-19 pandemic: technical problems with their COVID-19 testing kits, mixed messaging about the pandemic and mitigation strategies, and public commentary and interference by people in the Trump administration, for example. (more…)